CDE issues the 'Technical Guidelines for Pharmacological Changes Research of Listed Traditional Chinese Medicines (Trial)'
2021-07-09 00:00
To guide the change research of already listed Chinese medicine in our country and provide a reference technical standard, under the deployment of the National Medical Products Administration, the Center for Drug Evaluation organized the formulation of the "Technical Guidelines for Pharmacological Changes Research of Listed Traditional Chinese Medicines (Trial)" (see attachment). In accordance with the requirements of the "Notice on Issuing the Release Procedures for Drug Technical Guidelines" (Yaojianzongyaoguan [2020] No. 9) issued by the Comprehensive Office of the National Medical Products Administration, after review and approval by the National Medical Products Administration, it is now issued and implemented from the date of issuance.
This is hereby announced.
Center for Drug Evaluation, National Medical Products Administration
April 1, 2021
Next Page
Scan the QR code to contact online